Clinical Trials Logo

Chronic Kidney Failure clinical trials

View clinical trials related to Chronic Kidney Failure.

Filter by:

NCT ID: NCT03456232 Recruiting - Clinical trials for Chronic Kidney Failure

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

Start date: December 21, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.

NCT ID: NCT03437538 Completed - Dialysis Clinical Trials

Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter

Start date: May 21, 2018
Phase: N/A
Study type: Interventional

The Medium Cut-Off dialysis (MCO) membrane has been developed to improve middle molecule removal compared to standard high-flux dialysis filters. The major aim of this study is to compare the reduction ratio of middle molecules, during a single hemodialysis session with MCO-filter, compared to hemodiafiltration (HDF) with standard high-flux filter. Secondary aims are to compare the reduction ratio of small and large molecules between the treatments.

NCT ID: NCT03202212 Completed - Clinical trials for Chronic Kidney Failure

Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction

Start date: February 3, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

On line haemodiafiltration (OL-HDF) has been shown to improve intra-dialytic hemodynamics and cardiovascular outcomes. Several potential candidates of these beneficial effects have been explored. The aim of this study was to investigate the impact of mixed OL-HDF (mOL-HDF) on different circulating mediators of vascular dysfunction.

NCT ID: NCT03161197 Completed - Clinical trials for Chronic Kidney Diseases

Pain Relief Intervention of Meditation in Renal Disease (PRIMER)

PRIMER
Start date: April 24, 2015
Phase: N/A
Study type: Interventional

Kidney Disease subjects will be recruited to take part of a mindfulness-based stress reduction intervention for 8-10 sessions. All subjects will complete a baseline interview, one follow-up at 3 months and the close out interview at 5 months.

NCT ID: NCT03142529 Recruiting - Clinical trials for Chronic Kidney Failure

Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease

Start date: May 15, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates the clinical efficacy and study the therapeutic mechanism of a kind of traditional Chinese medicine colonic dialysis on Chronic kidney disease (CKD) 5 without blood dialysis therapy in adults. Half of participants will receive conventional integrated therapy on chronic renal failure (CRF), while the other half will receive integrated therapy on CRF and traditional Chinese medicine colonic dialysis.

NCT ID: NCT03076528 Completed - Diabetes Clinical Trials

An Innovative Virtually Supervised Exercise for Dialysis Patients

Start date: November 6, 2016
Phase: Phase 2
Study type: Interventional

Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation. The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility. Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.

NCT ID: NCT02913690 Active, not recruiting - Clinical trials for Chronic Kidney Failure

Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH)

PATCH
Start date: May 15, 2017
Phase: N/A
Study type: Interventional

This study aims to determine if tocotrienol rich fraction (TRF) supplementation can improve markers of inflammation, oxidative stress and blood lipids in Malaysian hemodialysis (HD) patients.

NCT ID: NCT02889575 Completed - Acute Renal Failure Clinical Trials

Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery

PIIINP-NGAL
Start date: April 2012
Phase: N/A
Study type: Observational

Acute Renal Failure (ARF) is defined by a severe, and usually reversible, glomerular filtration rate decreasing. Acute Tubular Necrosis (ATN) remain the major cause of ARF involving distress and destruction of tubular cells. This specific typology of ARF may evolve toward Chronic Renal Failure (CRF) concretizing a major public health issue. Predict the progression of ARF towards CRF appears essential. The investigators believe that the PIIINP and urinary NGAL biomarkers may constitute robust biomarkers of progression risk towards CRF.

NCT ID: NCT02586376 Completed - Clinical trials for Chronic Kidney Failure

Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF)

LLLTMSKF
Start date: October 2015
Phase: N/A
Study type: Interventional

The low-level laser therapy (LLLT) has been used in many inflammatory disorders. More recently the LLLT was associated with an improvement in the muscle strength and endurance. But, these effects were described only in health or athletic individuals. In this randomized and controlled clinical trails, the investigators will study the effects of LLLT on muscle strength of the patients with kidneys failure on long time hemodialysis treatment. Additionally, investigators will explore three different intensities up the muscle strength.

NCT ID: NCT02513303 Completed - Clinical trials for End Stage Renal Disease

Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

ACCESS
Start date: November 2015
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).